AnaBios primary human suspension hepatocytes are quality control tested for viability, cell yield post thaw, plating confluency, and CYP enzyme and mRNA induction (Lot ID: 1079).
Ideal for studies of drug metabolism, toxicity and disease modeling
AnaBios primary human suspension hepatocytes are quality control tested for viability, cell yield post thaw, plating confluency, and CYP enzyme and mRNA induction fold of CYP1A12, CYP2B6, and CYP3A4. Expanded hepatocytes form monolayers of hepatocytes attaching to collagen-coated surfaces for at least up to 5 days. (Lot ID: 1079)
- Cell Yield: >4 million
- Viability: 90%
- Suspension hepatocytes suiteable for short-term analysis
- Spheroid competency for 3D-based investigations
- Match your research requirements to our biobank of cryopreserved tissues
- Age: 6
- Sex: Male
- Race: Caucasian
- BMI: 16.9
- COD: Head Trauma/Blunt Injury
- Drug Use: No
- Alcohol Use: No
- Smoking Use: No
Donor: HIV, HCV, HBV, RPR
Culture: Gram+, Gram-, Mycoplasm, Fungi
ACCELERATE PREDICTIVE TRANSLATIONAL RESEARCH WITH ANABIOS HEPATOCYTES.
Hepatocytes play a key role in metabolism, detoxification, protein synthesis, and activating the immune system.
Cell Systems and AnaBios cells are available for in vitro research purposes only and may not be transferred out of the direct control of the recipient Institution/Agency/Organization. Cell Systems and AnaBios cells may not be genetically altered in any way without prior written permission from Cell Systems. Use of Cell Systems and AnaBios materials (evidenced by placement of any order for product) constitutes knowledge, understanding and binding acceptance of these restrictions on behalf of the recipient Institution/Agency/Organization.
Cell Systems was created to further the knowledge of eukaryotic cell biology through laboratory research, publications and teaching. Cell Systems and AnaBios provides cells and cell culture products to other research entities - public and private.